Sawicka, Barbara, Skiba, Dominika, Pszczółkowski, Piotr et al. · Cellular and molecular biology (Noisy-le-Grand, France) · 2020
This review examined Jerusalem artichoke, a root vegetable, to understand its nutritional and health benefits. The researchers found that Jerusalem artichoke contains compounds that may help with blood sugar control, weight management, immune function, and several chronic conditions including chronic fatigue syndrome. However, this is a review of existing research rather than a new experiment testing these benefits in patients.
Identifying plant-based compounds with immunostimulatory and metabolic properties is relevant to ME/CFS research, as the condition involves immune dysregulation and metabolic dysfunction. This review catalogs existing evidence on Jerusalem artichoke's bioactive compounds, which could inform future clinical trials in ME/CFS populations seeking evidence-based dietary interventions.
This review does not prove that Jerusalem artichoke supplementation is effective in ME/CFS patients, as it does not present new clinical trial data or patient outcomes. The review mixes mechanistic findings, animal studies, and preliminary human research without clearly distinguishing evidence quality, so efficacy and safety in ME/CFS remain unestablished. Chronic fatigue syndrome is mentioned as a potential application, but no specific studies on CFS patients are described.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →